Discover 1,846 paid clinical trials in Tennessee. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Whether you're a healthy volunteer interested in paid studies or someone looking for trials focused on specific conditions, Tennessee offers a wide variety of clinical research options. Leading facilities in Nashville, Memphis, and Knoxville are currently seeking participants, providing opportunities for individuals to access innovative treatments and specialized healthcare.
Filter
1
Filter results
Results: 1,846
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
for
Obesity, Metabolic Syndrome
Location: Nashville TN
Sponsor: Vanderbilt University Medical Center
Sex: All
Age: 18+
Code: NCT05972564
Phase1, Phase2, Recruiting
Safety and Efficacy of ST-100 (Vezocolmitide) Ophthalmic Solution 60 μg/ml Ophthalmic Solution in Subjects Diagnosed With Dry Eye Disease (DED)
for
Dry Eye Disease
Location: Memphis TN
Sponsor: ORA, Inc.
Sex: All
Age: 18+
Code: NCT06178679
Phase3, Recruiting
Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System
for
Tricuspid Regurgitation
Location: Lebanon NH, The Bronx NY, Cleveland OH, Atlanta GA,
Sponsor: Laplace Interventional, Inc
Sex: All
Age: 18 - 70+
Code: NCT06183684
Recruiting
Investigation of the Genetics of Hematologic Diseases
for
Bone Marrow Failure Syndromes, Erythrocyte Disorder,
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 0+
Code: NCT02720679
Recruiting
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
for
Locally Advanced Head and Neck Squamous Cell Carcinoma
Location: Fairhaven MA, Boston MA, Stony Brook NY, New York NY,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06129864
Phase3, Recruiting
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
for
Non-Small Cell Lung Cancer, NSCLC,
Location: Boston MA, Westbury NY, New York NY, Washington D.C. DC,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT06162221
Phase1, Phase2, Recruiting
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
for
Recurrent or Metastatic Solid Tumors
Location: Westbury NY, White Plains NY, New York NY, Fairfax VA,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06330064
Phase1, Phase2, Recruiting
The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease